Skip to main content
NCBI home page
British Journal of Sports Medicine logoLink to British Journal of Sports Medicine
. 1996 Mar;30(1):11–14. doi: 10.1136/bjsm.30.1.11

Resistance trained athletes using or not using anabolic steroids compared to runners: effects on cardiorespiratory variables, body composition, and plasma lipids.

R Yeater 1, C Reed 1, I Ullrich 1, A Morise 1, M Borsch 1
PMCID: PMC1332257  PMID: 8665108

Abstract

OBJECTIVE--To determine whether there is a difference in cardiac size and function as well as in body composition, aerobic capacity, and blood lipids between resistance trained athletes who use anabolic steroids and those who do not, and to compare them to university cross country athletes. METHODS--Four groups of men were evaluated: recreational lifters, n = 11, lifting < 10 h.week-1; heavy lifters, n = 16, lifting > 10 h.week-1; steroid users, n = 8, same as heavy lifters and used steroids; runners, n = 8, university track members. Echocardiograms, body composition (hydrostatic weighing), maximum oxygen consumption (Vo2), and lipids were studied. RESULTS--As expected, Vo2 (ml.kg-1.min-1), was greatest in the runners, with no difference among the lifting groups. High density lipoprotein cholesterol in the steroid user group was lower than in heavy lifters or runners. Left ventricular internal diastolic dimension was similar among the groups. The left ventricular mass index of the steroid user group was significantly greater than recreational lifters, at 161 v 103. There was no difference among heavy lifters (127), runners (124), and steroid users. There was no compromise in diastolic function in any group. There were no differences among groups in resting or exercise blood pressure. CONCLUSIONS--Resistance training in the absence of steroid use results in the same positive effects on cardiac dimensions, diastolic function, and blood lipids as aerobic training.

Full text

PDF
11

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alén M., Rahkila P. Anabolic-androgenic steroid effects on endocrinology and lipid metabolism in athletes. Sports Med. 1988 Dec;6(6):327–332. doi: 10.2165/00007256-198806060-00001. [DOI] [PubMed] [Google Scholar]
  2. BALKE B., WARE R. W. An experimental study of physical fitness of Air Force personnel. U S Armed Forces Med J. 1959 Jun;10(6):675–688. [PubMed] [Google Scholar]
  3. Baldo-Enzi G., Giada F., Zuliani G., Baroni L., Vitale E., Enzi G., Magnanini P., Fellin R. Lipid and apoprotein modifications in body builders during and after self-administration of anabolic steroids. Metabolism. 1990 Feb;39(2):203–208. doi: 10.1016/0026-0495(90)90076-o. [DOI] [PubMed] [Google Scholar]
  4. Bruce R. A. Exercise testing for evaluation of ventricular function. N Engl J Med. 1977 Mar 24;296(12):671–675. doi: 10.1056/NEJM197703242961206. [DOI] [PubMed] [Google Scholar]
  5. Bunt J. C., Going S. B., Lohman T. G., Heinrich C. H., Perry C. D., Pamenter R. W. Variation in bone mineral content and estimated body fat in young adult females. Med Sci Sports Exerc. 1990 Oct;22(5):564–569. doi: 10.1249/00005768-199010000-00004. [DOI] [PubMed] [Google Scholar]
  6. Fleck S. J., Henke C., Wilson W. Cardiac MRI of elite junior Olympic weight lifters. Int J Sports Med. 1989 Oct;10(5):329–333. doi: 10.1055/s-2007-1024923. [DOI] [PubMed] [Google Scholar]
  7. Friedewald W. T., Levy R. I., Fredrickson D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972 Jun;18(6):499–502. [PubMed] [Google Scholar]
  8. Fröhlich J., Kullmer T., Urhausen A., Bergmann R., Kindermann W. Lipid profile of body builders with and without self-administration of anabolic steroids. Eur J Appl Physiol Occup Physiol. 1989;59(1-2):98–103. doi: 10.1007/BF02396586. [DOI] [PubMed] [Google Scholar]
  9. Hurley B. F., Seals D. R., Hagberg J. M., Goldberg A. C., Ostrove S. M., Holloszy J. O., Wiest W. G., Goldberg A. P. High-density-lipoprotein cholesterol in bodybuilders v powerlifters. Negative effects of androgen use. JAMA. 1984 Jul 27;252(4):507–513. [PubMed] [Google Scholar]
  10. Longhurst J. C., Kelly A. R., Gonyea W. J., Mitchell J. H. Echocardiographic left ventricular masses in distance runners and weight lifters. J Appl Physiol Respir Environ Exerc Physiol. 1980 Jan;48(1):154–162. doi: 10.1152/jappl.1980.48.1.154. [DOI] [PubMed] [Google Scholar]
  11. Menapace F. J., Hammer W. J., Ritzer T. F., Kessler K. M., Warner H. F., Spann J. F., Bove A. A. Left ventricular size in competitive weight lifters: an echocardiographic study. Med Sci Sports Exerc. 1982;14(1):72–75. doi: 10.1249/00005768-198201000-00014. [DOI] [PubMed] [Google Scholar]
  12. Milliken M. C., Stray-Gundersen J., Peshock R. M., Katz J., Mitchell J. H. Left ventricular mass as determined by magnetic resonance imaging in male endurance athletes. Am J Cardiol. 1988 Aug 1;62(4):301–305. doi: 10.1016/0002-9149(88)90228-7. [DOI] [PubMed] [Google Scholar]
  13. Pearson A. C., Schiff M., Mrosek D., Labovitz A. J., Williams G. A. Left ventricular diastolic function in weight lifters. Am J Cardiol. 1986 Dec 1;58(13):1254–1259. doi: 10.1016/0002-9149(86)90392-9. [DOI] [PubMed] [Google Scholar]
  14. Pelliccia A., Maron B. J., Spataro A., Proschan M. A., Spirito P. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med. 1991 Jan 31;324(5):295–301. doi: 10.1056/NEJM199101313240504. [DOI] [PubMed] [Google Scholar]
  15. Roy A., Doyon M., Dumesnil J. G., Jobin J., Landry F. Endurance vs. strength training: comparison of cardiac structures using normal predicted values. J Appl Physiol (1985) 1988 Jun;64(6):2552–2557. doi: 10.1152/jappl.1988.64.6.2552. [DOI] [PubMed] [Google Scholar]
  16. Thompson P. D., Sadaniantz A., Cullinane E. M., Bodziony K. S., Catlin D. H., Torek-Both G., Douglas P. S. Left ventricular function is not impaired in weight-lifters who use anabolic steroids. J Am Coll Cardiol. 1992 Feb;19(2):278–282. doi: 10.1016/0735-1097(92)90478-6. [DOI] [PubMed] [Google Scholar]
  17. Ullrich I. H., Reid C. M., Yeater R. A. Increased HDL-cholesterol levels with a weight lifting program. South Med J. 1987 Mar;80(3):328–331. doi: 10.1097/00007611-198703000-00013. [DOI] [PubMed] [Google Scholar]
  18. Urhausen A., Hölpes R., Kindermann W. One- and two-dimensional echocardiography in bodybuilders using anabolic steroids. Eur J Appl Physiol Occup Physiol. 1989;58(6):633–640. doi: 10.1007/BF00418510. [DOI] [PubMed] [Google Scholar]
  19. Warner J. G., Jr, Yeater R., Sherwood L., Weber K. A hydrostatic weighing method using total lung capacity and a small tank. Br J Sports Med. 1986 Mar;20(1):17–21. doi: 10.1136/bjsm.20.1.17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Zuliani U., Bernardini B., Catapano A., Campana M., Cerioli G., Spattini M. Effects of anabolic steroids, testosterone, and HGH on blood lipids and echocardiographic parameters in body builders. Int J Sports Med. 1989 Feb;10(1):62–66. doi: 10.1055/s-2007-1024877. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Sports Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES